Document is current
Any future updates will be listed below
-
Authors
Adler, Stephen S.
Nyong, Emmanuel C.
Glabman, Raisa A.
Choyke, Peter L.
Sato, Noriko
-
Funding
Funding for this research was provided by:
U.S. Department of Health and Human Services (No. 75N91019D00024, Task Order No. 75N91019F00129)
National Institutes of Health
- License Information
-
More Information
Article History
Received: 14 February 2022
Accepted: 20 May 2022
First Online: 1 June 2022
Competing interests
: S.S.A., P.L.C., and N. S. filed a provisional patent application No. 63/191,103 on May 20th, 2021 with the United States Patent Office on this work. P.L.C. and N.S. are co-inventors of U.S. patent US/10,556,916 for cell labeling using <sup>89</sup>Zr-oxine technology and filed a divisional U.S. patent application No. 16/723,601 for <sup>89</sup>Zr-oxine synthesis and applications used in this study. E.N. and R.G. declare that they have no conflict of interest.
